Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEF0217 in Young Adults with Down Syndrome
NCT05748405Phase 2Completed
- Sponsor
- Aelis Farma
- Start
- Dec 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AEF0217 in Down syndrome, sponsored by Aelis Farma. Started Dec 2022; status: completed.
02
Drugs
AEF0217
03
Conditions
Down syndrome
Beyond the preview
Go deeper on NCT05748405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05748405.